Primary Record
valinomycin
- In stock
- 2,106 g
- Purity
- 99.8 %
- CAS
- 2001-95-8
Compound Identifiers & Properties
- CAS
- 2001-95-8
- PubChem CID
- 5649
- SMILES
- CC1C(=O)NC(C(=O)OC(C(=O)NC(C(=O)OC(C(=O)NC(C(=O)OC(C(=O)NC(C(=O)OC(C(=O)NC(C(=O)OC(C(=O)NC(C(=O)O1)C(C)C)C(C)C)C(C)C)C)C(C)C)C(C)C)C(C)C)C)C(C)C)C(C)C)C(C)C
- Canonical SMILES
- CC1OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC(=O)C(C)OC(=O)C(C(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)NC1=O
Names & Synonyms
- valinomycin
- Valinomicin
- valino
- Antibiotic N-329 B
- Potassium ionophore I
- AC1L1KTN
- (+)-VALINOMYCIN
- RefChem:1073554
- UNII-N561YS75MN
- SCHEMBL41016
- BSPBio_001226
- KBioGR_000566
- KBioGR_002478
- KBioSS_000566
- KBioSS_002485
- HSDB 6423
- GNF-Pf-5297
- CHEMBL602575
- 2001-95-8
- NSC 122023
- C54H90N6O18
- CHEBI:95123
- EINECS 217-896-6
- KBio2_000566
- KBio2_002478
- KBio2_003134
- KBio2_005046
- KBio2_005702
- KBio2_007614
- KBio3_001011
- KBio3_001012
- KBio3_002956
- CID5649
- Valinomycin, Streptomyces fulvissimus
- cMAP_000062
- FCFNRCROJUBPLU-UHFFFAOYSA-N
- Bio1_000384
- Bio1_000873
- Bio1_001362
- Bio2_000453
- Bio2_000933
- HMS1362N07
- HMS1792N07
- HMS1990N07
- HMS3403N07
- BRN 0078657
- BDBM50420225
- NSC122023
- AKOS024319642
- C54-H90-N6-O18
- NSC-122023
- IDI1_002208
- NCGC00095987-01
- NCGC00095987-02
- NCGC00095987-03
- AN-50245
- LS-15509
- J623.644H
- LS-161344
- FT-0675766
- 4-27-00-09728 (Beilstein Handbook Reference)
- Q27166904
- 6,18,30-trimethyl-3,9,12,15,21,24,27,33,36-nona(propan-2-yl)-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone
- 1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane- 2,5,8,11,14,17,20,23,26,29,32,35-dodecone, 12,24,36-trimetyl-3,6,9,15,18,21,27,30,33-nonakis(1-methylethyl)-
- Cyclic(D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-alpha-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl)
- 1,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone, 12,24,36-trimethyl-3,6,9,15,18,21,27,30,33-nonakis(1-methylethyl)-
- 1,7,13,19,25,31-Hexaaza-4,10,16,22,28,34-hexaoxa-6,9,12,18,21,24,30,33,36-nonaisopropyl-3,15,27-trimethylcyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone
- 3,6,9,15,18,21,27,30,33-nonaisopropyl-12,24,36-trimethyl-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone
- 6,18,30-trimethyl-3,9,12,15,21,24,27,33,36-nonakis(propan-2-yl)-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone
- Cyclo(D-.alpha.-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-.alpha.-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-.alpha.-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl)
- Cyclo(L-Val-D-HyIva-D-Val-L-Lac-)3: HyIva = alpha-Hydroxyisovaleric acid, Lac = Lactic acid
- WLN: T-36-MV DOV GMV JOV MMV POV SMV VOV B&MV E&OV H&MV K&OVTJ CY1&1 FY1&1I1 LY1&1 OY1&1 RY1&1 U1 A&Y1&1 D&Y1&1 G&Y1&1 J&1 M&Y1&1